Skip to main content
Clinical Trials/NCT04257305
NCT04257305
Completed
Not Applicable

A Cross-sectional Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical Inpatients

Huashan Hospital1 site in 1 country9,010 target enrollmentJune 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Venous Thromboembolism
Sponsor
Huashan Hospital
Enrollment
9010
Locations
1
Primary Endpoint
Rate of VTE occurrence
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Venous thromboembolism (VTE), comprising deep venous thrombosis (DVT), pulmonary embolism (PE), or both, is a life-threatening complication in postoperative patients. VTE has been estimated an incidence ranged from 79 per 100000 to 269 per 100000 population1. The incidence of VTE rises up to 3.0% in average among all postoperative neurosurgical patients in recent studies, but the number varies in a large range according to primary diseases. This cross-sectional study was aimed to investigate the incidence, associated risk factors, prophylaxis, treatment, and outcomes of VTE in a large clinical neurosurgery center in China.

Detailed Description

Venous thromboembolism (VTE), comprising deep venous thrombosis (DVT), pulmonary embolism (PE), or both, is a life-threatening complication in postoperative patients. This cross-sectional study was aimed to investigate the incidence, associated risk factors, prophylaxis, treatment, and outcomes of VTE in a large clinical neurosurgery center in China. 9010 patients underwent neurosurgery procedure were included. Distribution of age, sex, whether received PICC during perioperative period, and some special primary diseases are significantly different between VTE and non-VTE patients. Student's test and chi-square test were performed for analyses. We investigated VTE incidence, risk factors, prophylaxes, treatment and outcomes in postoperative neurosurgical patients, and summarized the VTE susceptible population of the patients, providing a VTE patient profile for neurosurgeons to concern.

Registry
clinicaltrials.gov
Start Date
June 1, 2018
End Date
December 31, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shengqing Li

Chief Physician,Professor

Huashan Hospital

Eligibility Criteria

Inclusion Criteria

  • Neurosurgical Inpatients. Underwent neurosurgery procedure.

Exclusion Criteria

  • Acute or chronic respiratory failure. Acute myocardial infarction or other serious heart diseases.

Outcomes

Primary Outcomes

Rate of VTE occurrence

Time Frame: 19 months

VTE incidence in postoperative neurosurgical patients during inhospital time from Jun 1,2018 to Dec 31,2019

Secondary Outcomes

  • Rate of complete vessel recanalization(19 months)
  • Rate of bleeding events(19 months)
  • Rate of partial vessel recanalization rate(19 months)

Study Sites (1)

Loading locations...

Similar Trials